Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes (Q84107453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Kevin M Friedman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Peter A Prieto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Laura E Devillier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

James C Yang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

John R Wunderlich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mark E Dudley

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

1 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

published in

Journal of Immunotherapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

400-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells

1 February 2020

cites work

1 reference

12 December 2020

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

1 reference

12 December 2020

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

12 December 2020

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

12 December 2020

Adoptive T cell therapy of cancer

1 reference

12 December 2020

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.

1 reference

12 December 2020

Tumor-specific Th17-polarized cells eradicate large established melanoma

1 reference

12 December 2020

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

1 reference

12 December 2020

Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Cancer regression in patients after transfer of genetically engineered lymphocytes

1 reference

12 December 2020

Trends in dermatology: melanoma incidence

1 reference

12 December 2020

Enrichment of CD8+ cells from melanoma tumor-infiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy.

1 reference

12 December 2020

CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion

1 reference

12 December 2020

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

1 reference

12 December 2020

T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.

1 reference

12 December 2020

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

1 reference

12 December 2020

Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma

1 reference

12 December 2020

Cancer statistics, 2009

1 reference

12 December 2020

Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen

1 reference

12 December 2020

CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells

1 reference

12 December 2020

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

1 reference

12 December 2020

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells

1 reference

12 December 2020

Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients

1 reference

12 December 2020

Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion

1 reference

12 December 2020

Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy

1 reference

12 December 2020

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

1 reference

12 December 2020

CD4+ T cells in adoptive immunotherapy and the indirect mechanism of tumor rejection

1 reference

12 December 2020

Identification of a novel major histocompatibility complex class II-restricted tumor antigen resulting from a chromosomal rearrangement recognized by CD4(+) T cells

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines

1 reference

12 December 2020

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

12 December 2020

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival

1 reference

12 December 2020

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

1 reference

12 December 2020

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression

1 reference

12 December 2020

Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy

1 reference

12 December 2020

1 reference

12 December 2020

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

1 reference

12 December 2020

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

1 reference

12 December 2020

Adoptive immunotherapy of cancer using CD4(+) T cells

1 reference

12 December 2020

CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.

1 reference

12 December 2020

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

1 reference

12 December 2020

10.1097/CJI.0B013E31825898C5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22576345%20AND%20SRC:MED&resulttype=core&format=json